Related Experiment Video
Updated: Aug 13, 2025

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications
Published on: February 23, 2019
In-Depth Analysis of Physiologically Based Pharmacokinetic (PBPK) Modeling Utilization in Different Application
Aleksandra Krstevska1,2, Jelena Đuriš1, Svetlana Ibrić1
1Department of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia.
Physiologically based pharmacokinetic (PBPK) modeling is increasingly applied in drug discovery and development. This review analyzes PBPK applications, revealing its use in early development, risk assessment, and predicting interactions, though model validation is less frequently reported.
Area of Science:
- Pharmacokinetics and Drug Development
- Computational Biology
- Toxicology
Background:
- Physiologically based pharmacokinetic (PBPK) modeling has seen limited elaboration in scientific literature regarding its diverse applications.
- A comprehensive analysis of PBPK modeling's distribution across research topics and validation methods is needed.
Purpose of the Study:
- To conduct an in-depth analysis of PBPK modeling applications and validation using text mining.
- To map the current landscape of PBPK modeling in drug discovery and development.
Main Methods:
- Text mining of 2699 articles retrieved from PubMed using Orange 3.32.0.
- Analysis of publication trends, application areas, and model validation methods.
Main Results:
- PBPK modeling publications are steadily increasing.
- Key application areas include early drug development (26%), absorption/formulation (25%), drug-disease interactions (20%), drug-drug interactions (17%), and pediatric development (12%).
- Model validation was mentioned in only 12% of publications, with literature-based (51%) and experimental (26%) validation being most common.
Conclusions:
- PBPK modeling is a growing field with diverse applications in drug discovery and development.
- There is a notable gap in reporting model validation, highlighting an area for future focus.
- This review provides a valuable overview of the state-of-the-art in PBPK modeling.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...